2026 TeoTwawKi ... 2032 Darkest Interregnum Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum

GLD 382.87

-0.8%

Nov 13 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pogeu Mahone who wrote (193453)	11/11/2022 1:04:03 PM
From: marcher	Read Replies (1) of 217753

--The risks were evident regardless of vaccination status.... ...reinfection further increases risks of death, hospitalization and sequelae in multiple organ systems in the acute and postacute phase. Reducing overall burden of death and disease due to SARS-CoV-2 will require strategies for reinfection prevention-- so, this seems to conclude that covid vaccination does not prevent reinfection. or am i misinterpreting something? --a strategy that would result in vaccines that are more durable, cover a broad array of variants (variant-proof vaccine strategy), reduce transmission (and subsequently reduce the risk of infection and reinfection) and reduce both acute and long-term consequences in people who get infected or reinfected is urgently needed. Other pharmaceutical and nonpharmaceutical interventions to lessen both the risk of reinfection and its adverse health consequences are also urgently needed.-- wondering what the nonpharmaceutical interventions might be...?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next